Morning Briefing
Summaries of health policy coverage from major news organizations
Financial Investment, Progress In HIV/AIDS Treatment Must Be Protected By International Patent Law
In this Hill opinion piece, John Castellani, CEO and president of the Pharmaceutical Research and Manufacturers of America, writes, "Over the past three decades, more than 30 treatments have been approved to treat HIV/AIDS," but he adds, "While this is remarkable progress, it's not enough." He continues, "In order for scientific progress in these areas to continue, the substantial financial investments in medicines created in America's biopharmaceutical labs -- medicines that take years and billions of dollars to develop -- must be protected by international patent laws."
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
